Due to health issues, this site is no longer maintained and will be shut down shortly. |
Warrant exercisable for one share at $11.50 per share This security was issued by Avista Public Acquisition Corp. II Class A, whose common stock symbol is AHPA.
On 3/23/2022 the company announced a proposed merger with OmniAb, Ligand’s antibody discovery business.
$0.35 -0.05 (-12.50%)
As of 11/02/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.